MedReleaf and BioPharma Services Inc. announce Strategic Alliance

MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") and BioPharma Services Inc. (BioPharma) today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.

Aurora Cannabis Signs Agreement with Heinrich Klenk GmbH & Co. KG

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH ("Pedanios"), has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG ("Klenk"), one of Europe's largest medicinal plant companies.

Organigram Announces First International Expansion Investment

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany.

Future Farm Agrees to Acquire 10% of Arizona Medical Marijuana Cultivation and Processing Management Company

Future Farm Technologies Inc. (the "Company" or "Future Farm") (CSE: FFT) (CSE: FFT.CN) (OTCQX: FFRMF) is pleased to announce that it has agreed to invest $500,000 for a 10% interest in a limited liability company (the "Arizona Operator"), providing turn-key services related to the management, administration and operation of a 70,000 square foot licensed medical marijuana cultivation and processing facility in the State of Arizona. The transaction is expected to close in the next 45 days.

MedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in Mind

MedReleaf Corp. (TSX:LEAF) Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced the introduction of AltaVie by MedReleaf, the Company's premium recreational cannabis brand designed for a premium consumer who is curious, discerning about life in general and searching for physical, mental and emotional enrichment.

MedReleaf to purchase 164 acre property, including 1 million square feet of existing greenhouse to add an additional 105,000 kg of fully funded capacity output

MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced that it has entered into agreements to acquire 1 million square feet of existing greenhouse infrastructure on a 69 acre property in Exeter, Ontario ("Exeter Facility") and 95 acres of adjacent land for $21.5 million in cash and 225,083 common shares of MedReleaf (the "Agreements").

Pages